See the pattern, not just the headline.

Precision Neuroscience raises $250 million to advance commercialization of its brain interface

Precision Neuroscience has closed a $250 million Series D, bringing total capital raised to $430 million. The company says the funding will expand its clinical program, advance its Layer 7 brain-computer interface through further FDA review and build commercialization infrastructure after more than 100 patient procedures.